Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Behaviour Research and Therapy|June 6, 2009
Predictors of attrition and weight loss success: Results from a randomized controlled trialAnthony N Fabricatore, Thomas A Wadden, Reneé H Moore, et al.
European Urology|August 7, 2023
Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature ReviewRobert J Motzer, Pratik P Rane, Todd L Saretsky, et al.
Lung|November 8, 2022
Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic CoughJonathan Schelfhout, Allison Martin Nguyen, Surinder S Birring, et al.
The Lancet. Respiratory Medicine|September 2, 2024
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trialSurinder S Birring, Linda Cardozo, Roger Dmochowski, et al.
Metabolism: Clinical and Experimental|January 20, 2012
Energy content of weight loss: kinetic features during voluntary caloric restrictionSteven B Heymsfield, Diana Thomas, Corby K Martin, et al.
Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.
Lung|March 6, 2023
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic CoughLorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2019
Does recall period matter? Comparing PROMIS<sup>®</sup> physical function with no recall, 24-hr recall, and 7-day recallDavid M Condon, Robert Chapman, Sara Shaunfield, et al.
Pageof 4